Prevenar™ Vaccination: Review of the Global Data, 2006
This article, published in the journal Vaccine, reviews the incidence of vaccine-serotype invasive pneumococcal disease and other pneumococcal-associated respiratory tract diseases following the routine use of the seven-valent pneumococcal conjugate vaccine, Prevenar™.
Author(s): Center KJ
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Center KJ. Prevenar™ Vaccination: Review of the Global Data, 2006. Vaccine. 2007;25(16):3085-3089.